H1-3

Mutation & survival
SurvivalMutationKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, H1-3 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated H1-3 data layer compared with 23 for mass-spec protein and 5 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher H1-3 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated H1-3 expression acts as an unfavorable survival marker.

COAD, SKCM, and BRCA are the cancer types where H1-3 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
COADOSMedianAll0.0560.871<.00145view →
SKCMOSMedianIII,IV0.1110.814<.00118view →
BRCADFSMedianAll0.1700.527.01210view →
DLBCOSMedianAll0.0530.936<.0016view →
Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

H1-3–COAD (OS)

Kaplan–Meier survival curve for H1-3 mutant vs wild-type samples in COAD.

Open the COAD breakdown →

Exploration